Stillidsvej 2 ApS: Financial statements 2022
CVR: 39012448
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
Stillidsvej 2 ApS (CVR 39012448) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -6,250 and a net result of DKK -4,893 compared with DKK -4,087 the year before. Equity in the 2022 report amounted to DKK 21,716. The solvency ratio was 43.4%.
- Gross Profit
- DKK -6,250
- Profit/Loss
- DKK -4,893
- Equity
- DKK 21,716
- Total Assets
- DKK 50,000
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | -6 t. | -5 t. | 22 t. | - |
| 2021 | - | -6 t. | -4 t. | 27 t. | - |
| 2020 | - | -4 t. | -7 t. | 31 t. | - |
| 2019 | - | 0 | 4 t. | 37 t. | - |
Official annual report
Keep an eye on Stillidsvej 2 ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
Stillidsvej 2 ApS has published its annual report for 2021. Gross profit came to DKK -6,250, and the net result was DKK -4,087.
About Stillidsvej 2 ApS
Stillidsvej 2 ApS is a Danish company of the type Anpartsselskab based in Egå, founded in 2017. The company is registered under the industry Detailhandel med andre fødevarer. The company was previously named CBD Pharma ApS. The management consists of Dan Ringsted Jacobsen and Lars Folkmann. The board consists of Dan Ringsted Jacobsen and Lars Folkmann. The company is owned by HPD Group ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -6,250 and a net result of DKK -6,350 compared with DKK -3,647 the year before. Equity in the 2025 report amounted to DKK 105,137.